✦ LIBER ✦

Novel anticancer agents for multiple myeloma: a review of the evidence for their therapeutic and economic value

✍ Scribed by Gaultney, Jennifer G ;Redekop, William K ;Sonneveld, Pieter ;Uyl-de Groot, Carin A

Book ID: 117996116
Publisher: Expert Reviews
Year: 2012
Tongue: English
Weight: 539 KB
Volume: 12
Category: Article
ISSN: 1473-7140
DOI: 10.1586/era.12.42

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multiple myeloma: A prototypic disease m

Multiple myeloma: A prototypic disease model for the characterization and therapeutic targeting of interactions between tumor cells and their local microenvironment

✍ Constantine S. Mitsiades; Nicholas S. Mitsiades; Paul G. Richardson; Nikhil C. M 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB

## Abstract The interaction between tumor cells and the local milieu where are homing has recently become the focus of extensive research in a broad range of malignancies. Among them, multiple myeloma (MM) is now recognized as a prototypical tumor model for the characterization of these interaction

Botulinum toxin as treatment for focal d

Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value

✍ Zoons, E.; Dijkgraaf, M. G. W.; Dijk, J. M.; Schaik, I. N.; Tijssen, M. A. 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 227 KB

Novel evidence of a role for chromosome

Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma

✍ Patricia Le Baccon; Dominique Leroux; Christina Dascalescu; Samuel Duley; Daniel 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 322 KB

## Abstract 1q rearrangement is a remarkably frequent secondary chromosomal change in both non‐Hodgkin's lymphoma (NHL) and multiple myeloma (MM), where it is associated with tumor progression. To gain insight into 1q rearrangement‐associated disease mechanisms, we used fluorescence in situ hybridi

Antithrombotic Agents After Peripheral T

Antithrombotic Agents After Peripheral Transluminal Angioplasty:a Review of the Studies, Methods and Evidence for their Use

✍ HR Watson; D Bergqvist 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Evidence for Cytogenetic and Fluorescenc

Evidence for Cytogenetic and Fluorescence In Situ Hybridization Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies

✍ Kapoor, Prashant; Fonseca, Rafael; Rajkumar, S. Vincent; Sinha, Shirshendu; Gert 📂 Article 📅 2010 🏛 Mayo Clinic 🌐 English ⚖ 827 KB

Circulating angiopoietin-1 to angiopoiet

Circulating angiopoietin-1 to angiopoietin-2 ratio is an independent prognostic factor for survival in newly diagnosed patients with multiple myeloma who received therapy with novel antimyeloma agents

✍ Evangelos Terpos; Konstantinos Anargyrou; Eirini Katodritou; Efstathios Kastriti 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 French ⚖ 456 KB 👁 1 views

## Abstract The circulating levels of several angiogenic cytokines [angiopoietin‐1 (Ang‐1), angiopoietin‐2 (Ang‐2), vascular endothelial growth factor (VEGF), angiogenin and basic fibroblast growth factor (bFGF)] were evaluated in 174 consecutive patients with newly diagnosed, symptomatic, multiple